Response to the Letter “Steatotic Liver Disease and the ‘Point of No Return’ in the Development of Metabolic Disorders”

Documenti analoghi

• Response to the Letter “Steatotic Liver Disease: A Key Related Risk Factor in the Emergence of Metabolic Syndrome‐Related Disorders”
  di: Yoshihiro Kamada
  Pubblicazione: (2026)
• Steatotic Liver Disease and the “Point of No Return” in the Development of Metabolic Disorders
  di: Tsutomu Nishida, et al.
  Pubblicazione: (2026)
• Steatotic Liver Disease: A Key Related Risk Factor in the Emergence of Metabolic Syndrome‐Related Disorders
  di: Yoshihiro Kamada, et al.
  Pubblicazione: (2025)
• Letter to the Editor: Steatotic Liver Disease: A Key Related Risk Factor in the Emergence of Metabolic Syndrome‐Related Disorders
  di: Jianing Hou, et al.
  Pubblicazione: (2026)
• Response to “Aspirin for Primary Prevention in Metabolic Dysfunction‐Associated Steatotic Liver Disease”
  di: Tsubasa Tsutsumi, et al.
  Pubblicazione: (2026)